POST-FEDERAL BUDGET RESPONSE: AUSTRALIAN THYROID FOUNDATION 1 million Australians with undiagnosed thyroid disorders remain at risk of irreparable damage
At the Post Budget Breakfast hosted by AIPS and Medicines Australia, the Honourable Mark Butler MP, Minister for Health and Aged Care spoke about the health priorities of the Federal Budget 2024-25.
As with all Federal Budgets, there is a submission process to lodge requests by January of each year. For the Federal Budget this year, there were 788 submissions lodged, one of which was by the Australian Thyroid Foundation (ATF).
The ATF is a national not-for-profit organisation with charity status aimed at patients and the healthcare community. The ATF’s focus is to support and educate its member base and promote our Good Thyroid Health Messaging throughout the Australian Community.
Australian Thyroid Foundation, CEO Beverley Garside attending the breakfast gave her response to the Federal Budget and the Foundation’s pre-budget submission, which was not granted.
The 3 requests for funding were for,
1. Education tool kit for health care professionals, to use during patient presentations
2. Broad media campaign aimed at young families moving away from standard dietary choices and awareness about the importance of iodine and thyroid health
3. Dietary book for senior Australians with an iodine slant to improve health outcomes, with healthy living choices.
According to the Australia Thyroid Foundation, over 1 million Australians are living with an undiagnosed thyroid disorder. These disorders can affect children, pregnant women, families and the elderly.
You Might also like
-
From University to Pharmacy Industry
The transition from full time academic study to industry can be both rewarding and challenging. Intern programs and an association for pharmacists, makes the transition easier.
The National Australian Pharmacy Students’ Association (NAPSA) represents students from 17 universities nationwide studying either an undergraduate or postgraduate program. The association advocates for Australian pharmacy students to ensure their future is prosperous and their status, rights and privileges are protected.
-
Jamie Stanistreet talks Medical Technology
Jamie Stanistreet
Retired Managing Director Medtronic Australia and New Zealand
talks Medical Technology in Australia and the Asia-Pacific -
Spinal implant technology eyes global opportunity
Adelaide, South Australia wants to let the secret out, and be known as hub for medical devices, pharmaceuticals, biotechnology, and digital health. It boasts world-class research institutions, such as the University of Adelaide and SAHMRI, fostering innovation and collaboration. The city’s supportive government policies provide incentives, grants, and streamlined regulations for businesses. Adelaide’s skilled workforce, renowned for its expertise in health sciences, offers a talent pool to drive industry growth. Additionally, the city’s strategic location, advanced infrastructure, and strong healthcare ecosystem make it an ideal base for development, manufacturing, and market access, attracting companies in these sectors.